Moderate evidenceWording 1
Claims Facts
“Supports normal blood clotting.”
| Daily dose | at least 11.25 µg a day |
|---|---|
| Support | Authorized in the EU after EFSA review; Health Canada lists no specific use. |
| Dose details | EU: at least 11.25 µg, 15% of the 75 µg EU reference value (Regulation (EU) No 1169/2011, Annex XIII). Health Canada’s monograph gives vitamin K1 and K2 at 6-120 µg a day for adults but lists no specific use for it. |
| Form | Vitamin K1 or K2, counted as total vitamin K |
| Source | Commission Regulation (EU) No 432/2012, list of permitted health claims |